On March 5, 2025, the Board of Directors (the “Board”) of Build-A-Bear Workshop, Inc. (the “Company”) increased the size of the Board to seven (7) members and appointed Richard A. Johnson to the Board.
On February 28, 2025, Emil Michael, a member of the Board of Directors (the “Board”) of Rent the Runway, Inc. (the “Company”), tendered his resignation from the Board and all committees on which he served, in each case, effective as of March 1, 2025.
Departed
Charles Benton
Director
VISION ENERGY Corp
Effective
2025-02-28
Filed
March 5, 2025, 6:59 PM ET
On February 28, 2025, each of Charles Benton and Judd Brammah notified Vision Energy Corporation (the “Company”) of his resignation as a director of the Company, effective immediately.
Departed
Judd Brammah
Director
VISION ENERGY Corp
Effective
2025-02-28
Filed
March 5, 2025, 6:59 PM ET
On February 28, 2025, each of Charles Benton and Judd Brammah notified Vision Energy Corporation (the “Company”) of his resignation as a director of the Company, effective immediately.
Effective February 28, 2025, Mr. Robert Feitler resigned from his position as a member of the Board of Directors (“Board”) of Weyco Group, Inc. (the “Company”).
Patrick A. Luis, Chief Credit Officer of Community West Bank (the "Bank"), notified the Bank of his decision to resign from his position with the Bank, effective February 28, 2025.
Patrick A. Luis, Chief Credit Officer of Community West Bank (the “Bank”), notified the Bank of his decision to resign from his position with the Bank, effective February 28, 2025.
and that Clarence L. Granger, the Chairman of the Board, will become the Company’s interim Chief Executive Officer on the effective date of Mr. Scholhamer’s resignation
On March 5, 2025, Ultra Clean Holdings, Inc. (the “Company”) issued a press release announcing that James P. Scholhamer has resigned, effective March 4, 2025, as the Company’s Chief Executive Officer and as a member of the Company’s Board of Directors
On February 28, 2025, Jiyoung Hwang resigned from the Board of Directors (the “Board”) of Exicure, Inc. (the “Company”) for personal reasons, effective immediately as of such date.
Effective immediately upon the transition of Mr. Kroeker to his new role at the Company, the Company appointed Eric Javidi to be the Company’s new Chief Financial Officer.
On March 5, 2025, Certara, Inc. (the “Company”) announced that Dr. Patrick F. Smith, President, Certara Drug Development Solutions, stepped down from that role as of March 3, 2025, but will remain employed by the Company in a senior advisory and scientific role.
Departed
Ellis Smith
Director
American Cannabis Company, Inc.
Effective
2025-02-27
Filed
March 5, 2025, 6:59 PM ET
The February 27, 2025, resignation of Ellis Smith was accepted by the Board at this meeting.
On March 3, 2025, the Board of Directors (the “Board”) of Lincoln National Corporation (the “Corporation” or “LNC”) approved an increase to the size of the Board effective the same date (as further discussed below under Item 5.03) and elected James Morris to serve as a new director on the Board effective March 3, 2025, for a term to end at the Corporation’s 2025 Annual Meeting of Shareholders.
To fill the vacancy on the Board created by Mr. Snavely's resignation, on February 28, 2025, the Board appointed Quyen Du as a Class III director to hold office until the Company's 2024 annual meeting of stockholders and until her successor shall have been duly elected and qualified or until her earlier death, resignation or removal.
The Company also announces that John R. Blind, a member of the Board and the lead independent director, is retiring at the expiration of his current term when a new director is elected at the Company’s 2025 Annual Meeting of Shareholders in July.
the Board appointed Trent Green as the Company’s Chief Executive Officer and to serve as a director, both effective June 1, 2025
Appointed
Tan Sze Thuan
director
Scorpius Holdings, Inc.
Effective
2025-03-03
Filed
March 4, 2025, 6:59 PM ET
On March 3, 2025, Scorpius Holdings, Inc., a Delaware corporation (the “Company”), increased the size of its Board of Directors to five members and appointed Tan Sze Thuan to serve as a director.
On February 26, 2025, Michael S. Liebowitz notified the Board of Directors (the “ Board ”) of Nocopi Technologies, Inc. (the “ Company ”) of his resignation as Chairman of the Board and Chief Executive Officer of the Company, effective immediately.
On March 4, 2025, the Board appointed Matthew C. Winger as the Company’s Chairman of the Board and Chief Executive Officer (and principal executive officer), effective immediately, to fill the vacancy created by Mr. Liebowitz’s resignation.
Effective as of the Separation Date, Celina A. Davila, currently the Chief Accounting Officer and principal accounting officer of the Company, will additionally assume the role of principal financial officer of the Company on an interim basis until a new Chief Financial Officer is appointed.
On March 4, 2025, ProPetro Holding Corp. (the “Company”) announced the departure of David S. Schorlemer from his role as Chief Financial Officer of the Company, effective March 3 , 2025
On February 28, 2025, David B. Kagan notified the Company of his resignation as a member of the Company’s Board of Directors, effective February 28, 2025.
As part of its corporate restructuring announced on February 28, 2025, Adagio Medical Holdings, Inc. (the “Company”), announced the departure of Hakon Bergheim, the Company’s Chief Operating Officer, effective February 28, 2025.
On March 3, 2025, Anthony Coelho, a director of AudioEye, Inc. (the “Company”), notified the Company of his decision to resign as a director of the Company, effective on March 3, 2025.
On March 4, 2025, MFA Financial, Inc. (the “Company”) announced that its Board of Directors (the “Board”) has elected Christopher Small as a director of the Company effective as of such date.
On February 28, 2025, Anthony Doyle, the Chief Financial Officer of BioCryst Pharmaceuticals, Inc. (the “Company”) notified the Company of his intention to resign from his employment with the Company, effective April 9, 2025.
On February 26, 2025, the Board of Directors (the “Board”) of the Company determined to appoint Mr. Maki as the Company’s full-time Chief Financial Officer, effective March 1, 2025.
William “Bill” Wagner, member of the board of directors (the “Board”) of BlackLine, Inc. (the “Company”) informed the Company that he intended to resign from the Board, effective as of the expected date of the Company’s annual stockholder meeting.
On February 28, 2025, Kathleen A. Murphy, a member of the Board of Directors (the “Board”) of Prudential Financial, Inc. (the “Company”), notified the Board that she will not stand for reelection to the Board at the Company’s next annual meeting of shareholders, to be held on May 13, 2025.
Departed
Laura Gault
Chief Medical Officer
Sage Therapeutics, Inc.
Effective
2025-03-21
Filed
March 4, 2025, 6:59 PM ET
On March 3, 2025, Laura Gault, M.D., Ph.D. notified Sage Therapeutics, Inc. (the “Company”) of her decision to resign as Chief Medical Officer of the Company, effective March 21, 2025, to pursue a new opportunity.
On February 28, 2025, in connection with the IPO, Messrs. Hudson and Furer and Ms. Tarbox (collectively with Messrs. Hendrix and Fishman, the “Directors”) were appointed to the board of directors of the Company (the “ Board ”).
On February 28, 2025, in connection with the IPO, Messrs. Hudson and Furer and Ms. Tarbox (collectively with Messrs. Hendrix and Fishman, the “Directors”) were appointed to the board of directors of the Company (the “ Board ”).
On February 28, 2025, in connection with the IPO, Messrs. Hudson and Furer and Ms. Tarbox (collectively with Messrs. Hendrix and Fishman, the “Directors”) were appointed to the board of directors of the Company (the “ Board ”).
Departed
Catherine R. Smith
Chief Financial Officer
NORDSTROM INC
Filed
March 4, 2025, 6:59 PM ET
On February 27, 2025, Catherine R. Smith, the Company’s Chief Financial Officer, informed the Company of her intention to step down from her role following the filing of the Company’s Annual Report on Form 10-K for the fiscal year ended February 1, 2025, anticipated to be within the next month.
On February 28, 2025, Lourinda St. John, Chief Human Resources Officer of Acuren Corporation (the “Company”), notified the Company that, due to personal reasons, she intends to resign from her current title and roles at the Company and all of its subsidiaries effective April 7, 2025.
Appointed
Denise Cruz
SVP, Chief Accounting Officer and Corporate Controller
Effective February 26, 2025, the Company appointed Denise Cruz, 53, as SVP, Chief Accounting Officer and Corporate Controller.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.